
On this page, you can update your details, access training courses, and find other helpful resources to support your business membership of Anaphylaxis UK.
Since our rebranding and new website in July 2022, we’ve already reached a staggering number of page views.
Our latest social media campaign reached over 650,000 unique people in 10 weeks with nearly 12,000 views on the campaign page and nearly 2,000 sign-ups to the campaign email.
Our Facebook page reaches 489,000 people and our organic post reach is over 72,500.
Our monthly newsletter has an open rate of over 56%.
Download the Anaphylaxis UK Business Member logos along with the Brand Guidelines. Please use the Brand Guidelines on how to correctly display the logos and link to the Anaphylaxis Homepage: https://www.anaphylaxis.org.uk/
The Anaphylaxis UK Business Member logos

The Anaphylaxis UK Brand Guidelines

Access training for you and colleagues here. The training courses are only available to Business Members.
Get the latest news. To feature news of your own, get in touch!
Anaphylaxis UK is delighted to announce a new partnership with the Out of School Alliance (OOSA) — a leading membership organisation supporting providers of wraparound care and holiday clubs across the UK. This collaboration will make it even easier for
Back in July, we welcomed the news that the UK medicines regulator (MHRA) had approved the country’s first needle-free adrenaline nasal spray, EURneffy® for people living with serious allergies. And in another positive step forward, EURneffy® is now available on prescription in the UK.
A new UK study led by Imperial College London, published in Archives of Disease in Childhood, finds that providing every school with spare adrenaline auto-injectors (AAIs) could improve emergency care for children and save the NHS at least £4.6 million a year.
Some of our Business Members are featured here.

Update your subscription details
Go nowUpdate your company details and logo
Go nowPlease complete the details below so we can set up your new account.